Company Filing History:
Years Active: 2016
Title: Praveen Raju: Innovator in Pharmaceutical Formulations
Introduction
Praveen Raju is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations targeting cancer treatment.
Latest Patents
Praveen Raju holds a patent for a "Tablet formulation of a phosphatidylinositol 3-kinase inhibitor." This invention focuses on compositions and methods that target the PI3K signaling pathway for the treatment or prevention of cancer. The pharmaceutical formulation comprises Polymorph E of N-(3-{[(2Z)-3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2(1H)-ylidene]sulfamoyl}phenyl)-2-methylalaninamide. This innovative approach aims to enhance the efficacy of cancer therapies.
Career Highlights
Praveen Raju is currently employed at Sanofi, a global healthcare company known for its commitment to innovation in pharmaceuticals. His work at Sanofi has allowed him to contribute to groundbreaking research and development in the field of medicine.
Collaborations
Praveen collaborates with Darshan Parikh, a fellow professional in the industry. Their partnership exemplifies the collaborative spirit that drives innovation in pharmaceutical research.
Conclusion
Praveen Raju's contributions to pharmaceutical formulations, particularly in cancer treatment, highlight his role as an innovator in the field. His patent and work at Sanofi reflect his commitment to advancing medical science and improving patient outcomes.